Skip to main content

PharmExpert LLC

International Pharmacovigilance for Comprehensive Drug Safety

PharmExpert' International Pharmacovigilance Processes are Presented in the PV System below. Click the blue buttons to get more.

Our International Pharmacovigilance Solutions

PharmExpert LLC provides a comprehensive range of international pharmacovigilance services to meet your global needs in the territories of Azerbaijan, Belarus, Georgia, Russia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan. 

  • QPPV and Local QPPV
  • PSMF Management
  • Literature Monitoring and Aggregate Reporting (PSURs, DSURs)
  • Regulatory Intelligence Monitoring
  • ICSR Management and Assessment of Benefit-Risk Ratio
  • Local Contact Person for Pharmacovigilance (LCPPV)
  • Risk Management Plans (RMPs) and Risk Minimization Activities
  • Pharmacovigilance Audit and Inspections
  • Pharmacovigilance Trainings
  • Safety Database and Signal Management
  • Medical Information Requests
  • Post-Authorization Safety Studies (PASS)
  • Outsourcing of Pharmacovigilance System.

No matter where your product is marketed in CIS/EAEU, our dedicated team ensures compliance with country-specific regulations, providing end-to-end support throughout the product lifecycle.

Looking for a Top Quality International Pharmacovigilance Consultant?

About Us: Your Trusted Partner in International Pharmacovigilance

PharmExpert is your trusted partner in delivering world-class international pharmacovigilance solutions, ensuring the safety and efficacy of medicinal products across global markets. Our expertise spans diverse therapeutic areas, with a focus on compliance in CIS and EAEU regions. From adverse event reporting to risk management planning, we provide tailored strategies to meet the unique challenges of international regulatory environments. At PharmExpert, we prioritize patient safety while empowering pharmaceutical companies with seamless, efficient, and compliant solutions throughout every stage of the product lifecycle.

Our Expertise

At PharmExpert, we empower healthcare businesses with advanced pharmacovigilance solutions tailored to meet the evolving needs of the pharmaceutical industry. Our commitment lies in ensuring stringent regulatory compliance and safeguarding patient safety through innovative and effective approaches. We specialize in a comprehensive suite of services, including meticulous monitoring, precise reporting, and insightful analysis of drug safety data. Our methodologies are designed to foster trust and transparency, bridging the gap between healthcare providers, regulatory authorities, and patients.

Our Key Aim

At PharmExpert, we are committed to excellence in every aspect of our operations. Our cornerstone is a robust Quality Management System meticulously designed and maintained in accordance with the internationally recognized ISO 9001:2015 quality standard and the rigorous pharmacovigilance GVP guidelines. This unwavering commitment reflects our dedication to ensuring the highest standards of quality, safety, and efficiency. Our key aim is not only to ensure the flawless execution of our processes but also to set benchmarks in quality management within the pharmacovigilance domain. Together, we strive to build a safer, more efficient future for healthcare systems worldwide.

Our main objectives

In line with this strategic vision, our main objectives are: 1) To provide adequate, reliable and regulatory compliance solutions; 2) Optimize the performance of Company’s business and pharmacovigilance processes by maintaining continuous improvement of Quality Management System; 3) Effectively address and satisfy any existing and projected needs of educational, training and professional development needs of employees and other stakeholders of the Company; 4) Build client loyalty by meeting or exceeding our customer expectations and contractual obligations.

Dynamics of the company's international expansion

  • 2019

    Company Creation

  • 2020

    2 Countries

  • 2021

    5 Countries

  • 2022

    7 Countries

  • 2023

    8 Countries

  • 2024

    10 Countries

  • 2025

    In progress

PharmExpert' International Pharmacovigilance Stat.

Active PV Projects

0

Satisfied Companies

0 %

SDEA Compliance

0 %

Regulatory Compliance

0 %

Why Choose PharmExpert for International Pharmacovigilance?

PharmExpert brings unmatched expertise in international pharmacovigilance by combining industry-leading technology, deep regulatory knowledge, and a client-centric approach. Our commitment to transparency, efficiency, and compliance makes us a trusted partner for pharmaceutical companies worldwide. We stay ahead of evolving regulatory standards to provide innovative solutions tailored to your needs.

We care for our clients’ business as our business. We think and act like business partners, not academic advisors. We share our clients’ aspirations, work to understand their reality, and align our incentives with their objectives — so they know we’re in this together.

Our Commitment to Compliance

We ensure seamless compliance with international regulatory frameworks, including EMA, FDA, and WHO guidelines. By collaborating closely with local regulatory authorities in CIS and EAEU regions, we enable smooth market access and continued product safety monitoring.

Global Reach, Local Expertise

Our network of qualified professionals spans the globe, offering both centralized and localized pharmacovigilance solutions. From QPPV representation to comprehensive risk management plans, our team is dedicated to supporting your operations across borders.

Continuous Improvements

We are a company that optimizes the performance of our business and international pharmacovigilance processes by maintaining continuous improvement of Quality Management System.

Local QPPV

Trusted local representatives ensuring compliance in key regions. Embrace the future of international pharmacovigilance with us.

Customer satisfaction

We are an international pharmacovigilance consulting provider that designs and builds client loyalty by meeting or exceeding our customer expectations and contractual obligations.

Professional Development and Trainings

We are a company that effectively addresses and satisfies any existing and projected needs of education, training and professional development of employees and other stakeholders of the Company.

Adverse Event Reporting

Streamlined systems for timely and accurate reporting in compliance with international standards.

Risk Management Plans

Robust strategies to minimize risks and ensure safe product usage.

Our Clients

Don’t Just Take Our Word for It

Rated 5 out of 5
"Working with PharmExpert has been a game-changer for our drug safety processes. Their expertise in pharmacovigilance ensures timely detection, reporting, and management of adverse drug reactions, help us meet regulatory compliance with ease. The team’s professionalism, attention to detail, and proactive approach greatly enhance our confidence in the safety and reliability of our products". 
Carl Bauer
CEO | German Pharma Company
Rated 5 out of 5
"We are extremely pleased with the PV services provided by PharmExpert Their team demonstrates exceptional expertise, efficiency, and attention to detail in managing our drug safety processes. From comprehensive adverse event reporting to ensuring regulatory compliance, they have streamlined our operations and provide us with peace of mind".
Alina Karlova
Global Drug Safety Head | Russian Drug Manufacturer
Rated 5 out of 5
“Partnering with PharmExpert has been a seamless and valuable experience for our pharmacovigilance needs. Their knowledgeable team delivers precise and timely support, ensuring full compliance with regulatory standards. Their dedication to quality and proactive approach has significantly improved our drug safety monitoring processes.”
Leyla Ahmad
PVQA | Italy Group Of Companies

FAQ

Ask Us Anything About International Pharmacovigilance

Pharmacovigilance is crucial for ensuring drug safety by detecting, assessing, and preventing adverse drug reactions (ADRs), especially post-marketing. It identifies rare or long-term side effects, enhances public trust, ensures regulatory compliance, and reduces healthcare costs. Pharmacovigilance supports risk-benefit analysis, improves patient safety, and helps detect medication errors. Overall, it protects public health and promotes safer, more effective medicines.

it’s a system that helps track and manage the safety of medicines once they’re in use by people, ensuring that any new problems or risks are identified and addressed promptly. You may check the flowchart on the top of this page to better understanding how the PV system run.

Thank you for your inquiry. To provide you with an accurate and competitive quotation, we kindly request that you share the details of your pharmacovigilance project. Understanding your specific requirements will allow us to tailor our services to your needs and offer you the optimal balance of quality and cost. We are committed to delivering the best value while maintaining the highest standards of service.

We are a dedicated pharmacovigilance consulting services provider with a strong track record of expertise and reliability. Our team comprises highly qualified professionals with 5-10 years of combined experience in pharmacovigilance, regulatory compliance, and risk management. We have successfully supported a diverse range of clients, including pharmaceutical, biotechnology, and clinical research organizations, ensuring the safety of medicinal products across global markets. Our comprehensive services cover case processing, signal detection, risk management planning, aggregate reporting, and regulatory submissions. This extensive experience positions us to deliver high-quality, client-centric solutions tailored to meet the unique challenges of the industry.

PharmExpert provides all of the services (En-to-End) available in the drug safety field. 

Latest Drug Safety Updates & Expert Articles

WHO’s 2026 Smart Pharmacovigilance Resolution: What WHA79.11 Means for Marketing Authorisation Holders

In May 2026, the 79th World Health Assembly adopted Resolution WHA79.11 on smart and efficient pharmacovigilance. The resolution places medicine,...
Read More
Gene and Cell Therapies: A Pharmacovigilance Perspective

Gene and Cell Therapies: A Pharmacovigilance Perspective

Gene and cell therapies are revolutionizing the way we treat diseases—sometimes by targeting the problem at its genetic roots, other...
Read More
Pharma 4.0 in Pharmacovigilance: Safer Drugs Ahead

Pharma 4.0 in Pharmacovigilance: Safer Drugs Ahead

Understanding Pharma 4.0 in Pharmacovigilance Pharma 4.0 takes inspiration from Industry 4.0, emphasizing the use of advanced technologies like Artificial...
Read More
Pharmacovigilance Staff Shortage in 2026: Solutions

Pharmacovigilance Staff Shortage in 2026: Solutions

Updated 15 July 2026. A shortage of pharmacovigilance professionals creates risks not only for reporting timelines but also for the...
Read More
QPPV and LPPV Roles in 2026: Responsibilities

QPPV and LPPV Roles in 2026: Responsibilities

Updated 15 July 2026. The qualified person responsible for pharmacovigilance (QPPV) and the local pharmacovigilance contact person (LPPV/LCPPV) provide governance...
Read More
Types of Pharmacovigilance in 2026: Complete Overview

Types of Pharmacovigilance in 2026: Complete Overview

Types of Pharmacovigilance in 2026: Complete Overview Updated 15 July 2026. Modern pharmacovigilance combines passive reporting, active surveillance, real-world data,...
Read More
Pharmacovigilance Compliance Checklist 2026

Pharmacovigilance Compliance Checklist 2026

Pharmacovigilance Compliance Checklist 2026 Updated 15 July 2026. This practical checklist supports MAH audit and inspection readiness and should be...
Read More
Pharmacovigilance Training in 2026: Course Programme

Pharmacovigilance Training in 2026: Course Programme

Updated 15 July 2026. Pharmacovigilance training in 2026 should build more than awareness of terminology: it should demonstrate that personnel...
Read More
The World Drug Safety Congress

The World Drug Safety Congress

The World Drug Safety Congress: A Platform for Advancing Pharmacovigilance and Drug Safety The World Drug Safety Congress (WDSC) is...
Read More
Semaglutide Safety in 2026: Updated Scientific Review

Semaglutide Safety in 2026: Updated Scientific Review

Updated 15 July 2026. Semaglutide is a GLP-1 receptor agonist used under approved indications for type 2 diabetes and chronic...
Read More
Active Pharmacovigilance in 2026: Methods and Use

Active Pharmacovigilance in 2026: Methods and Use

Active Pharmacovigilance in 2026: Methods and Practical Use Updated 15 July 2026. Active pharmacovigilance is the targeted search for safety...
Read More
Pharmacovigilance in Belarus in 2026: MAH Requirements

Pharmacovigilance in Belarus in 2026: MAH Requirements

Pharmacovigilance in Belarus in 2026: Requirements for Marketing Authorisation Holders Updated 15 July 2026. Belarus is a member of the...
Read More
Local QPPV(LQPPV) in CIS, EAEU, Georgia, Ukraine

Local QPPV(LQPPV) in CIS, EAEU, Georgia, Ukraine

Local QPPV (LQPPV) in CIS, EAEU, Georgia, and Ukraine: Ensuring Regional Pharmacovigilance Compliance Pharmacovigilance (PV) plays a vital role in...
Read More
Pharmacovigilance in Tajikistan in 2026: MAH Requirements

Pharmacovigilance in Tajikistan in 2026: MAH Requirements

Pharmacovigilance in Tajikistan in 2026: MAH Requirements Updated 15 July 2026. Pharmacovigilance in Tajikistan is governed by national medicinal product...
Read More
Pharmacovigilance in Uzbekistan in 2026: MAH Requirements

Pharmacovigilance in Uzbekistan in 2026: MAH Requirements

Pharmacovigilance in Uzbekistan in 2026: New MAH Requirements Updated 15 July 2026. Uzbekistan substantially updated its pharmacovigilance framework in 2026....
Read More
Pharmacovigilance in Georgia

Pharmacovigilance in Georgia

Pharmacovigilance in Georgia in 2026: Requirements for Marketing Authorisation Holders Updated 15 July 2026. Pharmacovigilance in Georgia is governed by...
Read More
Pharmacovigilance in Turkmenistan in 2026: MAH Guide

Pharmacovigilance in Turkmenistan in 2026: MAH Guide

Updated 15 July 2026. Pharmacovigilance in Turkmenistan is governed by national medicines legislation and subordinate requirements of the Ministry of...
Read More
Pharmacovigilance in Kyrgyzstan in 2026: MAH Requirements

Pharmacovigilance in Kyrgyzstan in 2026: MAH Requirements

Updated 15 July 2026. Pharmacovigilance in the Kyrgyz Republic is governed by national legislation and applicable Eurasian Economic Union (EAEU)...
Read More
Pharmacovigilance in Ukraine in 2026: MAH Requirements

Pharmacovigilance in Ukraine in 2026: MAH Requirements

Updated 15 July 2026. Ukraine’s national pharmacovigilance system is based on the Pharmacovigilance Procedure approved by Ministry of Health Order...
Read More
Pharmacovigilance in Kazakhstan in 2026: MAH Requirements

Pharmacovigilance in Kazakhstan in 2026: MAH Requirements

Updated 15 July 2026. Pharmacovigilance in Kazakhstan is governed by national legislation and applicable Eurasian Economic Union (EAEU) law. Marketing...
Read More
Pharmacovigilance in Azerbaijan in 2026: MAH Requirements

Pharmacovigilance in Azerbaijan in 2026: MAH Requirements

Updated 15 July 2026. Azerbaijan’s pharmacovigilance system is governed by national legislation and overseen by the Ministry of Health and...
Read More
Pharmacovigilance in the EAEU and CIS in 2026: MAH Requirements

Pharmacovigilance in the EAEU and CIS in 2026: MAH Requirements

Updated 15 July 2026. Pharmacovigilance in the Eurasian Economic Union (EAEU) and the wider CIS region is not one uniform...
Read More
Pharmacovigilance Regulatory Affairs

Pharmacovigilance Regulatory Affairs

A Critical Interface in Drug Safety and Compliance Pharmacovigilance regulatory affairs represent the intersection between pharmacovigilance, which focuses on monitoring...
Read More
CIOMS in Pharmacovigilance in 2026: Forms and Guidance

CIOMS in Pharmacovigilance in 2026: Forms and Guidance

CIOMS in Pharmacovigilance in 2026: Forms, Working Groups and Practical Use Updated 15 July 2026. The Council for International Organizations...
Read More
Pharmacoepidemiology and Drug Safety in 2026

Pharmacoepidemiology and Drug Safety in 2026

Pharmacoepidemiology and Drug Safety in 2026 Updated 15 July 2026. Pharmacoepidemiology studies the use, effectiveness and safety of medicines in...
Read More
Pharmacovigilance Slideshare

Pharmacovigilance Slideshare

Pharmacovigilance and the Role of SlideShare in Knowledge Dissemination Abstract Pharmacovigilance (PV) refers to the science and activities related to...
Read More
Clinical Trials and Pharmacovigilance in 2026

Clinical Trials and Pharmacovigilance in 2026

Clinical Trials and Pharmacovigilance in 2026 Updated 15 July 2026. Participant safety must be monitored from protocol design through site...
Read More
Pharmacovigilance in Russia in 2026: MAH Requirements

Pharmacovigilance in Russia in 2026: MAH Requirements

Pharmacovigilance in Russia in 2026: Requirements for MAHs Updated 15 July 2026. Pharmacovigilance in Russia is governed by both national...
Read More